Andrew Shutterly
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Andrew Shutterly
Andrew Shutterly is recorded as CFO at Altimmune, Inc. (ALT). Altimmune, Inc. reported in an 8-K filed June 26, 2024 that Andrew Shutterly was appointed acting Chief Financial Officer, "principal financial officer" and "principal accounting officer", effective June 25, 2024.
“On June 25, 2024, the Board of Directors (the "Board") of Altimmune, Inc. (the "Company") appointed Andrew Shutterly as acting Chief Financial Officer, "principal financial officer" and "principal accounting officer," effective immediately following the unexpected death of Richard Eisenstadt, the Company's Chief Financial Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Altimmune, Inc.
Other people whose current roles at this company are on record from its filings.
- Jerome Durso CEO, Board Member
- Vipin K. Garg CEO
- William Enright CEO
- Elizabeth A. Czerepak CFO
- Richard I. Eisenstadt CFO
- Richard Menziuso Chief Accounting Officer
- Catherine Angell Sohn Board Member
- Catherine Sohn Board Member
- Diane Jorkasky, M.D. Board Member
- Jerry Durso Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.